Language Model-based Virtual Screening

Language Model-based
Virtual Screening

LMVS screens 10 Billion Compounds
— potentially active drug candidates.

LM-VS™ screens
10 Billion compounds

to identify potentially active drug candidates.

LMVS screens 10 Billion Compounds
— potentially active drug candidates.

Over 70% cost reduction in hit discovery
achieved through AI automation — start now.

Over 70% cost reduction
in hit discovery achieved
through AI automation
— start now.

10B

Compound Library

10B

Compound Library

10B

Compound Library

50

AI Learning Loops

50

AI Learning Loops

50

AI Learning Loops

$20K

Per Target Protein

$20K

Per Target Protein

$20K

Per Target Protein

200

Top Candidates

200

Top Candidates

200

Top Candidates

LM-VS™ screens even for the most challenging targets — GPCR, MG, TPD, etc.

GPCR Target

We identify anchor residues within Open-Close membrane protein pockets to stabilize the ligand scaffold and initiate virtual screening.

Molecular Glue

We search for a molecular glue that acts as an adhesive between two weakly interacting proteins, thereby strengthening their interaction.

Target Protein Degrader

We identify the optimal compound that binds to the two pockets present in the degrader and the target, and then design a linker using the scaffolds of both compounds.

The entire process can be automatically executed
— on the STB Cloud

Planning

>

IV

>

LM-VS™

>

PAV

Step 1

Step 1

Step 1

Concetrated triathlete grayscale
Concetrated triathlete grayscale

IV — Scaffold Design by MD simulation

Among the 10 MD snapshots, 1,4-difluorobenzene showed the least movement and was therefore selected as the scaffold, which is highlighted in red in Figure 1.

In Figure 2, R2 ring cluster indicates that the red-colored ring region interacts most frequently with the protein residues.

Coach explaining something to an athlete
Coach explaining something to an athlete

Step 2

Step 2

Step 2

LM-VS™ — 10 Billion Compound Screening

By representing compound bonds within the pocket as 1D word strings and performing a Google-style inverted indexing search across a 10-billion-compound library, ultra-fast retrieval (as fast as 1/7000 second) becomes possible.

Compounds selected based on 1D string similarity are then re-docked, and those filtered by binding energy and scaffold similarity are defined as hit candidates.

In each iteration, the top 200 candidates are used for subsequent searches, and by repeating this process for 50 to 100 cycles, it becomes possible to screen scaffold-derived analogs that are synthetically accessible or commercially available.

Athlete winning a race
Athlete winning a race

Step 3

Step 3

Step 3

PAV – View*Summary*Ranking

  1. Post-Anal-View
    This result visualizes the docking within the protein pocket, where the anchor residues (in yellow) interacting with the compound scaffold are fixed in position. The remaining portions of the compound are displayed as the screened derivatives, as shown in the figure.

  1. Summary Report
    (A) Hit Candidates Distribution — A 3D scatter plot illustrates the distribution of hit candidates according to CNNaffinity, CNNscore, and Ring Match Score.
    (B) Accumulation of Hit Counts per Run — The cumulative number of strong and moderate hits is shown as the runs progress.

  1. Excel Report & Function Rank
    This report includes vendor information for compound  synthesis and provides a functional score calculated from affinity parameters (CNNscore, CNNaffinity) and ADME descriptors (MW, LogP, HBA, HBD, MolMR, Solubility, Caco2 permeability, Rotatable Bonds, Strain Energy) according to the following formula.

Concetrated triathlete grayscale
Concetrated triathlete grayscale

AI redefines the pace of discovery.
Curious how it works?

Explore LM-VS™ — from input to insight.

Speed. Reliability. Scale.

Our 5MW AI Bio Supercom Center runs 5,000+ GPUs in parallel,
screening 10 billion compounds and generating results instantly.

5MW AI Bio Supercom Center

5,000+ CPU/GPU clusters

Massively parallel high-performance cores

4kW power + 20Mbps dedicated bandwidth per node

Independent cluster architecture for real-time stability

Instant results with zero data loss

AI efficiency redefines discovery.
Complete hit discovery for just $20K.

LM-VS™ isn’t about being cheaper — it’s about being smarter.

LM-VS™ isn’t about being cheaper —
it’s about being smarter.

$20,000

/Per Target Protein

$20,000

/Per Target Protein

$20,000

/Per Target Protein

Timeline

Within 3 weeks

AI Learning Loops

Up to 50 Iterative Optimization

Compound Library

10 Billion (Enamine, Synple, SAVI & ZINC)

Deliverables

Top 200 Candidates Report + Structure Dataset

Turn your Hit into a Lead — for free.

Submit your SMILES string, and our AI will analyze its scaffold
to identify the most promising candidates from a 10B compound library.
Receive up to 200 lead molecules in your inbox — at no cost.

FAQ

FAQ

FAQ

How is AI screening different from traditional experiments?

What are the key benefits of using LM-VS™?

Can AI-generated results be directly applied to experiments?

How long does the analysis take?

What deliverables are included?

Is LM-VS™ applicable to all protein targets?

How is data security managed?

How do I request a quote or start a project?

How is AI screening different from traditional experiments?

What are the key benefits of using LM-VS™?

Can AI-generated results be directly applied to experiments?

How long does the analysis take?

What deliverables are included?

Is LM-VS™ applicable to all protein targets?

How is data security managed?

How do I request a quote or start a project?

How is AI screening different from traditional experiments?

What are the key benefits of using LM-VS™?

Can AI-generated results be directly applied to experiments?

How long does the analysis take?

What deliverables are included?

Is LM-VS™ applicable to all protein targets?

How is data security managed?

How do I request a quote or start a project?

No waiting. Just results — LM-VS™

Achieve results beyond what’s possible.

Contact Us

Contact Us

© Syntekabio Co., Ltd. All rights reserved.

Sales/Partnerships

bd@syntekabio.com

Family Sites

Family Sites

Sales/Partnerships

bd@syntekabio.com

© Syntekabio Co., Ltd. All rights reserved.

Family Sites

Sales/Partnerships

bd@syntekabio.com

© Syntekabio Co., Ltd. All rights reserved.

Create a free website with Framer, the website builder loved by startups, designers and agencies.